<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>19579900</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>García González, Jorge</dc:author>
<dc:author>López López, Rafael</dc:author>
<dc:author>León Mateos, Luis</dc:author>
<dc:author>Pérez Fentes, Daniel</dc:author>
<dc:author>Aliste Santos, Carlos</dc:author>
<dc:author>Suárez Peñaranda, José M</dc:author>
<dc:description xml:lang="en">Sarcomatoid bladder carcinoma is a high-grade neoplasm and accounts for approximately 0,3% of all bladder malignancies. Sarcomatoid carcinoma originates from transitional cells of the bladder. Sarcomatoid carcinoma is charactericed by a epithelial component and a sarcomatoid component, consisting of spindle cells, that is only epithelial marker-positive. We report a 26-year-old woman diagnosed of stage III sarcomatoid bladder carcinoma (T3aN0M0) treated with partial cistectomy followed by 4 cycles of adjuvant chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2009 Apr </dc:date>
<dc:title xml:lang="es">Empleo de M-VAC en el tratamiento adyuvante del carcinoma sarcomatoide de vejiga.</dc:title>
<dc:title xml:lang="en">[Use of M-VAC in the adjuvant treatment of sarcomatoid carcinoma of the bladder].</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
